Drug name - Vyzulta
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8058467 | BAUSCH AND LOMB | Prostaglandin derivatives |
Jan, 2025
(2 years from now) | |
| US7910767 | BAUSCH AND LOMB | Prostaglandin derivatives |
Jan, 2025
(2 years from now) | |
| US7273946 | BAUSCH AND LOMB | Prostaglandin derivatives |
Oct, 2025
(3 years from now) | |
| CN100469765C | BAUSCH AND LOMB | Prostaglandin Nitroxide Derivative |
Dec, 2024
(2 years from now) | |
| CN1906159A | BAUSCH AND LOMB | The Prostaglandin Nitroxide Derivative |
Dec, 2024
(2 years from now) | |
| IN276779B | BAUSCH AND LOMB | Prostaglandin Nitrooxyderivatives |
Dec, 2024
(2 years from now) | |
| IN200603240P1 | BAUSCH AND LOMB | Prostaglandin Derivatives |
Dec, 2024
(2 years from now) | |
| EP1704141B1 | BAUSCH AND LOMB | Prostaglandin Nitrooxyderivatives |
Dec, 2024
(2 years from now) | |
| EP1704141A1 | BAUSCH AND LOMB | Prostaglandin Nitrooxyderivatives |
Dec, 2024
(2 years from now) | |
| EP3002277B1 | BAUSCH AND LOMB | Prostaglandin Derivatives |
Dec, 2024
(2 years from now) | |
| EP3002277A1 | BAUSCH AND LOMB | Prostaglandin Derivatives |
Dec, 2024
(2 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7629345 | BAUSCH AND LOMB | Prostaglandin derivatives |
Jan, 2025
(2 years from now) | |
Drugs and Companies using LATANOPROSTENE BUNOD ingredient
Treatment: Reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension
Dosage: SOLUTION/DROPS;OPHTHALMIC
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.024% | SOLUTION/DROPS;OPHTHALMIC | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.